在胰腺癌局部和高级阶段的Codon-特定KRAS突变的预后影响
Sara Raji1, Hamed Zaribafzadeh1, Tyler Jones2
1Department of Surgery, Duke University School of Medicine, Durham, NC.
JCO precision oncology
|February 19, 2026
概括
在胰腺癌中,特定的KRAS突变会根据疾病阶段对患者的生存有不同的影响. 了解这种变异性对于评估KRAS抑制剂疗法至关重要.
科学领域:
- 在瘤学瘤学.
- 遗传学 是一个遗传学.
- 分子生物学分子生物学
背景情况:
- KRAS突变是胰腺管腺癌 (PDAC) 的关键驱动因素.
- 不同疾病阶段的特定KRAS编码因变化的预后影响尚不清楚.
- 仅有有限的数据可以将基因组资料与PDAC患者的详细临床信息联系起来.
研究的目的:
- 调查子特异性KRAS突变与PDAC中的临床基因组特征之间的关联.
- 确定这些突变对局部和晚期疾病阶段患者结果的影响.
- 分析基于特定KRAS变化的总生存 (OS) 差异.
主要方法:
- 使用了AACR GENIE生物制药联盟胰腺v1.2数据集.
- 分析了PDAC的1,032名符合条件的患者,重点关注子特定的KRAS突变.
- 使用Kaplan-Meier和Cox比例危险模型比较整体存活率.
主要成果:
- 92%的患者患有突变KRAS,G12D,G12V和G12R是最常见的.
- 在局部PDAC中,KRAS G12V比G12D (P=.03) 的存活时间更长.
- 在先进的PDAC中,KRAS G12V的OS比G12R和G12D更短 (P=.04对两者来说).
- 在KRAS突变之间没有发现共同改变的驱动基因 (TP53,CDKN2A,SMAD4) 的显著差异.
结论:
- 根据疾病阶段,codon特定的KRAS突变对PDAC结果产生差异性影响.
- 为了准确的治疗疗效评估,需要考虑KRAS突变的预后变异性.
- 这凸显了在KRAS抑制剂临床试验中根据特定的KRAS突变对患者进行分层的重要性.
更多相关视频
06:51Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018
18.8K
06:57Utilizing High Resolution Ultrasound to Monitor Tumor Onset and Growth in Genetically Engineered Pancreatic Cancer Models
Published on: April 7, 2018
11.5K
相关概念视频
02:38The Ras Gene
7.4K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Ras is a...
7.4K
01:33Cancer-Critical Genes I: Proto-oncogenes
11.6K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
11.6K
03:03mTOR Signaling and Cancer Progression
4.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.9K
02:07Tumor Progression
7.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.5K